You are here

Member Profile

Membership type: full

Soumi Sukla

Country of origin: India Currently in: India, Kolkata General field of specialization: Biological Systems and Organisms
Academic Background


2006 Doctorate Biological Systems and Organisms
Research and Profession

Current Research Activities

Biological Systems and Organisms

Currently working on dengue virus and a newly associated virus in Indian Leishmaniasis.

Publications resulting from Research: 

Selected publication
1. Sukla S, Ghosh A, Saha R, De A, Adhya S, Biswas S (2018) In-depth molecular analysis of a small cohort of human and Aedes mosquito (adults and larvae) samples from Kolkata revealed absence of Zika but high prevalence of dengue virus. Journal of Medical Microbiology doi: 10.1099/jmm.0.000769. [Epub ahead of print]

2. Sukla S, Roy S, Sundar S & Biswas S (2017). Leptomonas seymouri narna-like virus 1 and not leishmaniaviruses detected in kala-azar samples from India. Archives of Virology, 162: 3827-35
Research highlights:
a. “Scientists link new virus to kala-azar” – Research findings published in the National Daily newspaper, The Hindu, on 28th October, 2017
b. “New light on kala-azar” – Research highlights published in Nature India on 21st December, 2017

3. Gaspar M, May JS, Sukla S,* Frederico B, Gill MB, et al. (2011). Murid Herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathogen, 7(11): e1002346. doi:10.1371/journal.ppat.1002346 (*Joint first author)

4. Sukla S, Biswas S, Birkmann A, Lischka P, Zimmermann H & Field HJ (2010). Mis-match primer based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor. Journal of Antimicrobial Chemotherapy, 65: 1347-52

5. Sukla S, Biswas S, Birkmann A, Lischka P, Ruebsamen-Schaeff H, Zimmermann H & Field HJ (2010). Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant. Antiviral Research, 87: 67-73

Current profession

Current professional activities type: 

Search form